Solutions
Pricing
Log in
Teams
Get started
Log in
Get started
Untitled
ES
by
Emani Street
·
3 views
·
Updated Apr 8, 2022
Share
Embed
Re-use content
Create your own
Chapters
00:00
Antiviral Agents By Emani Street and Kiana Wimberly
00:07
What are antivirals?
00:10
Antivirals are medications that help your body fight off certain viruses that can cause disease.
00:36
Who created antiviral drugs?
00:41
Gertrude Elion
01:58
How do antiviral medications work?
02:05
Antiviral medicines work differently depending on the drug and virus type.
02:29
How does a virus work?
02:34
What is the body's first defense?
02:39
How does a virus work?
03:16
What is the body's first defense?
03:21
-Innate Immune System; Level One -Physical Barriers: tears, sweat, etc.
04:32
What are some examples of meds and Their Target HIV?
04:39
-Protease inhibitors (e.g., ritonavir, saquinavir, and indinavir) -Fusion Inhibitors
05:18
What are some examples of meds and their target Influenza ?
05:24
-The ‘flu” is a directly replicated virus -Method is to make proteins to form new viral particles
05:38
What are some examples of meds and their Target RSV?
05:39
-The ‘flu” is a directly replicated virus -Method is to make proteins to form new viral particles
06:17
What are some examples of meds and their Target RSV?
06:23
-Respiratory syncytial virus -Treatment: nucleoside analogue ribavirin activated by phosphorylation
07:10
What are some examples of meds and their target INTERFERONS ?
07:17
-Nonspecific antiviral -Very limited use
08:02
Conclusion
Audio Transcript
Auto-generated
00:00 - 00:03
Hello. My name is Amani Street and my name is Kiana Wimberly
00:04 - 00:06
and our topic is antiviral agents.
00:08 - 00:10
What our antivirus
00:12 - 00:16
antiviral medications help the body fight off harmful viruses.
00:16 - 00:21
The drug can ease symptoms and shorten the length of a viral infection.
00:21 - 00:26
Antivirals also lower the risk of getting or spreading viruses
00:26 - 00:29
that can cause herpes. And HIV
00:29 - 00:33
one approved antiviral treats the coronavirus that causes
00:33 - 00:34
Covid 19
00:38 - 00:40
who created antiviral drugs
00:43 - 00:44
grew trade
00:47 - 00:49
Richard Elian.
00:49 - 00:54
When news broke in April that the drug remdesivir had
00:54 - 00:59
been shown to speedy recovery and patients hospitalized with COVID-19
00:59 - 01:04
Anthony director of the US National Institute of Allergy and infectious diseases,
01:04 - 01:08
held the findings as an important proof of concept
01:08 - 01:11
in the race to bring the pandemic to heal.
01:13 - 01:15
Unlike a vaccine which prompts the body
01:15 - 01:18
to mount a defense against invading viruses.
01:18 - 01:21
Remdesivir is an anti drug
01:21 - 01:26
which helps hampers the ability of the virus to replicate and spread.
01:27 - 01:31
For now, results related to remdesivir are mixed.
01:31 - 01:36
Although some studies continues to suggest the drug can improve outcomes for
01:36 - 01:41
patients with severe forms of COVID-19 still only a few decades ago,
01:41 - 01:42
most scientists
01:42 - 01:43
would doubt such a thing.
01:44 - 01:50
Now. Antivirals are used to treat herpes, Hepatitis HIV Ebola and more
01:50 - 01:53
and arguably none would exist today
01:53 - 01:55
if it were not for Richard
01:56 - 01:56
Trudy
01:57 - 01:57
Elian,
02:01 - 02:04
how do anti viral medications work?
02:04 - 02:08
Anti viral medications work differently depending on the drug
02:09 - 02:10
and various types
02:11 - 02:12
I mean and virus types.
02:13 - 02:15
Antivirals can block receptors.
02:15 - 02:20
Cell viruses can't bind to and enter healthy sales boost
02:20 - 02:23
the immune system helping get fighting off a viral infection
02:24 - 02:25
and lower the viral load
02:26 - 02:28
which is the amount of active virus in the body.
02:31 - 02:33
So how does the virus work?
02:40 - 02:48
The way in which a virus works is through steps of attachment membrane fusion,
02:48 - 02:53
endorse atrocious replication assembly and budding and then viral envelope.
02:53 - 02:56
The virus begins by attaching to the wholesale,
02:56 - 03:01
endures the process of membrane fusion and endo psychosis to enter the sale.
03:01 - 03:05
It then invades the nucleus of a sale and releases its own R. N. A.
03:06 - 03:09
From here it uses organelles within the cell to replicate.
03:09 - 03:13
Its RNA viral particles are produced destroying the sale and the
03:13 - 03:16
virus are released into the body to continue the process.
03:19 - 03:21
So what is the body's first defense?
03:22 - 03:26
The innate immune system which is the level one defense
03:26 - 03:28
of the body includes physical barriers such as tears,
03:28 - 03:32
sweat, saliva and mucus produced by the skin and mucosa lining.
03:34 - 03:37
So what does the body do once? The level one defense doesn't work.
03:37 - 03:40
Mucous tissues and organs inside the body are
03:40 - 03:42
lined with a protective substance called mucus.
03:42 - 03:46
Mucus plays an important role in the protection of epithelial cells from
03:46 - 03:50
invading pathogens in the respiratory gastrointestinal
03:50 - 03:53
visual and auditory systems of animals.
03:53 - 03:55
Mucus is the major component of mucus.
03:56 - 03:58
Our family of high molecular weight black oh proteins
03:58 - 04:02
produced by the epithelial tissues in both vertebrates and invertebrates
04:03 - 04:05
mutants are able to form a gel like
04:05 - 04:08
barrier to protect sales from viral attachment and have
04:08 - 04:13
been shown to form a shield to trap viral particles such as HPV with sizes as little of
04:14 - 04:17
50 nm as well as HIV,
04:18 - 04:23
which is 120 nanometers and H. S. V, which is 180 nanometers.
04:24 - 04:26
Porcine gastric mucus may be used as
04:26 - 04:30
antiviral agents for future biomedical applications.
04:34 - 04:38
So what are some examples of medications and their targets? HIV
04:41 - 04:46
HIV medications use protease inhibitors, fusion inhibitors,
04:46 - 04:49
antagonists and post attachment inhibitors.
04:49 - 04:54
Protease inhibitors slow the emergence of resistant virus and inhibits the
04:54 - 04:57
viral enzymes involved in the synthesis of new viral particles.
04:58 - 05:01
Fusion inhibitors worked while blocking the HIV virus from
05:01 - 05:05
entering human cells and antagonists and post attachment inhibitors
05:06 - 05:09
which are used together block different types of
05:09 - 05:12
molecules on the immune cells surface to prevent
05:12 - 05:17
HIV from entering the sales and blocks the ability of the HIV virus to replicate.
05:21 - 05:25
Another example of a medication and its target would be the flu.
05:26 - 05:31
The flu, which is formally known as influenza, is a directly replicated virus.
05:31 - 05:35
It's method is to make proteins to form new viral particles.
05:38 - 05:42
Oh, sell tomato beer, which is
05:42 - 05:44
an active medication
05:46 - 05:50
works against both influenza A and influenza B.
05:50 - 05:54
It is a drug classified as inhibitors of neuro many days.
05:54 - 05:56
A glycoprotein on the surface of the
05:56 - 06:00
influenza virus inhibition of neuraminidase activity,
06:00 - 06:03
decreases the release of virus from infected cells,
06:03 - 06:06
increases the formation of viral aggregates
06:06 - 06:08
and decreases the spread of the virus through the body
06:09 - 06:11
When taken within 30 hours of infection.
06:11 - 06:14
This medication has the ability to shorten the
06:14 - 06:17
duration of infection as well as relief symptoms.
06:21 - 06:22
RSV
06:25 - 06:30
RSV which stands for respiratory symptoms, virus sink tissue virus.
06:31 - 06:35
It's a potentially fatal lower respiratory disease and Children.
06:35 - 06:40
The only pharmacological therapy available for treatment
06:40 - 06:42
of the infection is the nuclear side analog
06:43 - 06:44
ribavirin,
06:44 - 06:46
which can be administered orally
06:46 - 06:48
or by inhalation.
06:48 - 06:53
ribavirin must also be activated by false correlation. In order to be effective.
06:53 - 06:58
An injectable humanized monoclonal antibody is available for prevention
06:58 - 07:01
of RSV infection and high risk infants and Children.
07:01 - 07:04
It provides passive immunity and must be given by
07:04 - 07:08
intra muscular injection once a month during the RSV season
07:13 - 07:14
interference
07:17 - 07:19
interference represent
07:20 - 07:23
a group of non specific antiviral proteins
07:23 - 07:25
produced by wholesales in response to viral
07:25 - 07:30
infections as well as in response to the injection of double stranded RNA.
07:31 - 07:35
Some protocol and bacterial components and other chemical substances
07:35 - 07:36
interfere.
07:36 - 07:39
Our results in the production of a protein that prevents the
07:39 - 07:43
synthesis of viral components from the viral nucleic acid template.
07:44 - 07:46
The interference are of interest because
07:46 - 07:49
they have a broad spectrum antiviral activity
07:49 - 07:53
and because they can be used to inhibit the growth of cancer tissue.
07:53 - 07:57
However, the use of interference is limited by adverse effects.
07:57 - 08:00
A relative lack of efficacy and the
08:00 - 08:03
requirement for local and intravenous administration.
08:06 - 08:07
In conclusion,
08:08 - 08:13
current development of broad spectrum antiviral agents targeting viral
08:13 - 08:17
infectivity and modulating host defense system has substantially advanced
08:17 - 08:23
the field of virology and pharmaceutics and significantly significantly
08:23 - 08:25
contributed to the health care of human and animals.
08:25 - 08:26
However,
08:26 - 08:28
there are concerns of viral resistance
08:28 - 08:31
associated with agents targeting viral components
08:31 - 08:33
and non specific side effects
08:33 - 08:36
associated with agents targeting cellular machineries
08:36 - 08:41
accordingly. How to reduce viral resistance and increase drug specifically are
08:41 - 08:43
current challenges to be addressed.
08:44 - 08:46
Whether combined uses of agents to target
08:46 - 08:49
both viral components and cellular machineries may approve
08:49 - 08:51
antiviral efficacy,
08:52 - 08:56
reduce viral resistance and minimize toxicity in the control of
08:56 - 09:01
viral infection and epidemic viral diseases needs to be clarified.
09:02 - 09:02
Thank you.
See full transcript